From the only company selling nutraceutical products containing the neuroprotective dietary ingredient G-Agmatine®, Gilad&Gilad is excited to announce the launch of AgmaVet® For Horses, a new product dedicated to promoting resilient nerve functions and alleviating joint discomfort.
Osteoarticular (OA) health deterioration is very common in animals, as it is in humans. It affects some 30-50% of dogs, cats, and horses. In horses, its annual impact is as high as $1 billion.
Scientific evidence indicates that improper nerve functions underlie the tremendous discomfort caused by deteriorating OA health. This explains why existing treatments to maintain joint health are of limited effect and yield inconsistent results. “There is a clear unmet need for safe and effective natural dietary products that can relieve aches and leg weakness by promoting both resilient nerve functions and proper joints mobility,” said Dr. Gad M. Gilad, CEO of Gilad&Gilad.
Gilad&Gilad developed AgmaVet® For Horses based on substantial scientific research and clinical trials. A recently published clinical trial has demonstrated that oral G-Agmatine® can improve OA-associated lameness as well as protect horses from developing gastric ulcers, a serious side effect of existing treatments (J. Clin. Med.2022, 11(24), 7283).
AgmaVet® For Horses together with AgmaVet® (for small animals) and AgmaSet® (a human dietary supplement) belong to the Agmaceuticals® line of patent protected products containing the neuroprotective ingredient G-Agmatine®. These first-in-class products are superior to existing means for sustaining resilient nerve functions and proper joint mobility.
